Generate Biomedicines, Inc. - 10-Q Filing

Generate Biomedicines reports Q3 financial results highlighting ongoing R&D investment and collaboration activity with Amgen, Novartis, and Zealand.

SEC EDGAR · November 12, 2026, 12:06 UTC

Tickers: $GENB

More Regulatory news

United KSK Corp - 10-Q Filing SEC EDGAR · November 12, 2026, 16:29 UTC
AMERICAN SHARED HOSPITAL SERVICES - 8-K Filing SEC EDGAR · November 12, 2026, 16:27 UTC
VIVIC CORP. - 10-K Filing SEC EDGAR · November 12, 2026, 16:26 UTC
WOLVERINE WORLD WIDE INC /DE/ - 10-Q Filing SEC EDGAR · November 12, 2026, 16:24 UTC
BlueOne Technologies, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 16:20 UTC
Newton Golf Company, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 16:14 UTC
XBiotech Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 15:53 UTC
Cohen & Co Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 15:48 UTC
UNITED BANCORP INC /OH/ - 10-Q Filing SEC EDGAR · November 12, 2026, 15:33 UTC
PATRIOT GOLD CORP - 10-Q Filing SEC EDGAR · November 12, 2026, 15:32 UTC